Galectin-3, galactose-binding lectin |
Galectin-3 implicated in the development of chemoresistance in several solid as well as hematological cancers |
(59) |
B-ALL/Galectin-3 |
Galectin-3 protects ALL cells by auto-induction of galectin-3 mRNA and activation of the NFκB pathway and Wnt/β-catenin signaling pathway |
(178,179) |
Ph+ B-ALL/Galectin-3 |
Galectin-3 transcript levels upregulated in Ph+ B-ALL cells that had developed resistance to tyrosine kinase inhibitor nilotinib |
(180) |
CML/Galectin-3 |
Galectin-3 induced multi-drug resistance by activation of Akt and ERK and preventing apoptosis |
(181) |
Multiple myeloma/Galectin-3 |
Galectin-3 implicated in chemoresistance mechanisms |
|
Chemoprotective factor/ALL |
This soluble factor induces an increase in calcium influx into mitochondria, which leads to an increase in reactive oxidation species (ROS) in ALL cells. Cells respond by undergoing a redox adaptation to decrease ROS, thereby reducing ALL sensitivity to drug treatment |
(77) |
Chemoprotective factor/AML |
This soluble factor promotes chemoresistance by blocking the activity of equilibrative nucleoside transporter (ET1) which regulates cytarabine incorporation inside the cell |
(182) |